Dexmetomidine Intrathecally and Intravenously Additionally to Spinal Anaesthesia, in Total Knee Arthroplasty
Status:
Unknown status
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The present study is designed to evaluate and compare the efficacy of intrathecal
dexmedetomidine (DEX) as an adjuvant to Levobupivacaine in spinal anaesthesia and DEX's
intravenous administration, without loading dose, additionally to spinal anaesthesia, in
patients undergoing total knee arthroplasty.